Cel-Sci Corporation Common Stock (NY:CVM)

1.350 +0.100 (+8.00%)

Streaming Delayed Price Updated: 10:34 AM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cel-Sci Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

CEL-SCI Corporation Reports First Quarter Fiscal 2023 Financial Results

February 15, 2023

From CEL-SCI Corporation

Via Business Wire

Tesla To $250? Here Are 10 Other Price Target Changes For Thursday ↗

December 29, 2022

Morgan Stanley cut Tesla, Inc. (NASDAQ: TSLA) price target from $330 to $250. Morgan Stanley analyst Adam Jonas maintained an Overweight rating on the stock. Tesla shares rose 4.4% to $117.65 in...

Via Benzinga

CEL-SCI Reports Fiscal 2022 Financial Results and Clinical & Corporate Developments

December 28, 2022

From CEL-SCI Corporation

Via Business Wire

10-Year Phase 3 Trial Shows CEL-SCI's Multikine immunotherapy Extends Lives In Head & Neck Cancer Patients ↗

November 22, 2022

Via Benzinga

CEL-SCI Corporation Issues Letter to Shareholders

November 22, 2022

From CEL-SCI Corporation

Via Business Wire

Why Pinterest Shares Are Trading Higher; Here Are 27 Stocks Moving Premarket ↗

October 28, 2022

Gainers Zovio Inc (NASDAQ: ZVO) rose 39.5% to $0.2449 in pre-market trading after gaining 7% on Thursday.

Via Benzinga

CEL-SCI’S Multikine Reduced 5-year Death Rate From 54% to 22% in Phase 3 Study Patients Who Were Early Tumor Responders Prior to Any Standard of Care Treatment

October 17, 2022

From CEL-SCI Corporation

Via Business Wire

CEL-SCI’S Phase 3 Data Presented at ESMO 2022: Neoadjuvant Multikine Achieved Groundbreaking Tumor Response & Extended Overall Survival in Locally Advanced Head and Neck Cancer

September 12, 2022

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Corporation Issues Letter to Shareholders

September 07, 2022

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Corporation Announces Phase 3 Multikine® Head and Neck Cancer Results Posted on Clinicaltrials.gov

August 19, 2022

From CEL-SCI Corporation

Via Business Wire

This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday ↗

August 16, 2022

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.

Via Benzinga

CEL-SCI Corporation Reports Third Quarter Fiscal 2022 Financial Results

August 15, 2022

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Appoints Dr. Gail Naughton to Its Board of Directors

August 08, 2022

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Corporation Announces Reddit AMA with Geert Kersten

July 14, 2022

From CEL-SCI Corporation

Via Business Wire

TinyGemsBreaks – SRAX Inc. (NASDAQ: SRAX) Shares Replays of 2022 LD Micro Invitational Company Presentations

June 16, 2022

Via Investor Brand Network

Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday ↗

July 18, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering...

Via Benzinga

CEL-SCI Corporation to Present at LD Micro Invitational

June 08, 2022

From CEL-SCI Corporation

Via Business Wire

Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session ↗

July 15, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.

Via Benzinga

CEL-SCI Presents Phase 3 Multikine Head & Neck Cancer Data at ASCO

June 07, 2022

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Announces Publication of ASCO 2022 Abstracts

May 27, 2022

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Corporation Reports Second Quarter Fiscal 2022 Financial Results

May 16, 2022

From CEL-SCI Corporation

Via Business Wire

CEL-SCI Announces Acceptance of Abstracts to ASCO 2022

April 22, 2022

From CEL-SCI Corporation

Via Business Wire

28 Stocks Moving In Wednesday's Mid-Day Session ↗

April 20, 2022

Gainers Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) climbed 58.3% to $2.2950 after jumping around 22% on Tuesday. AlloVir, Inc. (NASDAQ: ALVR) shares climbed 39% to $7.52...

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 21, 2022

Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum...

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $...

Via Benzinga

54 Biggest Movers From Yesterday ↗

April 20, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...

Via Benzinga

34 Stocks Moving In Monday's Mid-Day Session ↗

April 18, 2022

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions....

Via Benzinga

68 Biggest Movers From Yesterday ↗

April 19, 2022

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...

Via Benzinga

CEL-SCI Corporation Reports First Quarter Fiscal 2022 Financial Results

February 14, 2022

From CEL-SCI Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022 ↗

April 07, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.